Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Transcription factor NEUROD1 is a key marker distinguishing bladder small cell carcinoma (SmCC) from prostate SmCC. This finding aids in classifying bladder cancer subtypes and developing targeted therapies.
Area Of Science
- Uro-oncology
- Molecular pathology
- Cancer biology
Background
- Small cell carcinoma (SmCC) of the bladder is a rare and aggressive cancer.
- Understanding its subtypes through transcription factor (TF) expression can guide targeted therapies.
Purpose Of The Study
- Investigate lineage-specific TF expression in bladder SmCC.
- Correlate TF expression with clinicopathological features.
- Compare bladder SmCC with prostate SmCC.
Main Methods
- Retrospective analysis of 9 bladder SmCC and 6 prostate SmCC cases.
- Immunohistochemistry for TFs (ASCL1, NEUROD1, POU2F3, YAP1) and neuroendocrine markers.
- Statistical analysis using Fisher's exact test and t-tests.
Main Results
- Bladder SmCC frequently showed combined morphology (urothelial carcinoma/adenocarcinoma) compared to prostate SmCC (78% vs 17%).
- NEUROD1 expression was significantly higher in bladder SmCC (67%) than prostate SmCC (0%).
- NEUROD1 was highly expressed in bladder SmCC with combined UC (100%), while HNF4A was absent; other bladder SmCC showed the inverse pattern.
Conclusions
- NEUROD1 expression is characteristic of bladder SmCC, particularly when combined with urothelial carcinoma, differentiating it from prostate SmCC.
- TF-based classification holds promise for improving diagnostic accuracy and therapeutic strategies in bladder cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...